Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Guangzhou Baiyunshan Pharmaceutical Holdings Company ( (HK:0874) ) has shared an announcement.
Guangzhou Baiyunshan Pharmaceutical Holdings Company has signed a new continuing connected transactions agreement with its controlling shareholder Guangzhou Pharmaceutical Holdings Limited (GPHL) to govern a wide range of intra-group dealings from 1 January 2026 to 31 December 2026, replacing existing agreements that expire at the end of 2025. The new framework covers purchases and sales of pharmaceuticals and other goods, mutual provision and receipt of labour services such as advertising and R&D, entrusted processing arrangements, trademark and trade name licensing, and cross-leasing of properties and equipment, and is structured so that the anticipated transaction caps trigger reporting, announcement and annual review obligations under Hong Kong listing rules but remain exempt from independent shareholders’ approval, underscoring the regulated yet operationally integral nature of these related-party transactions for the group’s ongoing business with GPHL.
The most recent analyst rating on (HK:0874) stock is a Buy with a HK$21.00 price target. To see the full list of analyst forecasts on Guangzhou Baiyunshan Pharmaceutical Holdings Company stock, see the HK:0874 Stock Forecast page.
More about Guangzhou Baiyunshan Pharmaceutical Holdings Company
Guangzhou Baiyunshan Pharmaceutical Holdings Company is a Chinese joint stock company in the pharmaceutical industry, focusing on the production and distribution of pharmaceuticals, medicinal materials, and related products and services. The group operates across the value chain, including manufacturing, sales, processing, and various support services, and maintains close business ties with its controlling shareholder Guangzhou Pharmaceutical Holdings Limited (GPHL) and its subsidiaries.
YTD Price Performance: 7.51%
Average Trading Volume: 1,211,494
Technical Sentiment Signal: Buy
Current Market Cap: HK$44.07B
For detailed information about 0874 stock, go to TipRanks’ Stock Analysis page.